Literature DB >> 11430909

Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARgamma mRNA expression in 3T3-L1 adipocytes.

T Takamura1, E Nohara, Y Nagai, K Kobayashi.   

Abstract

To clarify the target phase of thiazolidinediones, which are ligands for peroxisome proliferator-activated receptor (PPAR)gamma, during adipocyte differentiation, the effects of a thiazolidinedione, pioglitazone, on every stage during the course of adipocyte differentiation were investigated. Pioglitazone did not affect the cellular protein content and [3H]thymidine incorporation into preconfluent 3T3-L1 preadipocytes. Induction of differentiation of confluent 3T3-L1 preadipocytes with insulin, dexamethasone and isomethylbutylxanthine for 48 h resulted in 30% inhibition of [3H]thymidine incorporation into the cells and 354% increase in cellular protein content. Pioglitazone at 1 microM accelerated the increase in cellular protein content by 33% and the inhibition in the [3H]thymidine incorporation by 12%. Pioglitazone, when added from the start of the induction stage, dose-dependently enhanced cellular triglyceride accumulation, and both basal and insulin-stimulated glucose transporting activity producing only a slight increase in the ratio of insulin stimulation to basal glucose transporting activity. In mature adipocytes, however, pioglitazone did not enhance either of the transporting activities. PPARgamma messenger RNA (mRNA) levels estimated by a semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) increased during the course of adipocyte differentiation. Although pioglitazone dose-dependently up-regulated PPARgamma mRNA levels in postconfluent preadipocytes without induction, it down-regulated them in mature adipocytes. Thus, a PPARgamma agonist, pioglitazone, arrested the growth, and increased protein content and PPARgamma mRNA levels in postconfluent preadipocytes, followed by commitment and hypertrophy of 3T3-L1 cells without changing insulin sensitivity, whereas it failed to stimulate glucose transporting activities and down-regulated PPARgamma mRNA expression in mature adipocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11430909     DOI: 10.1016/s0014-2999(01)01053-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  A WD-FYVE protein binds to the kinases Akt and PKCzeta/lambda.

Authors:  Thorsten Fritzius; Gabriela Burkard; Elvira Haas; Jochen Heinrich; Marc Schweneker; Magnus Bosse; Sven Zimmermann; Alexander D Frey; Antje Caelers; Andre S Bachmann; Karin Moelling
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

2.  PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1.

Authors:  Patricia C Chui; Hong-Ping Guan; Michael Lehrke; Mitchell A Lazar
Journal:  J Clin Invest       Date:  2005-07-07       Impact factor: 14.808

Review 3.  PPARgamma as a new therapeutic target in inflammatory bowel diseases.

Authors:  L Dubuquoy; C Rousseaux; X Thuru; L Peyrin-Biroulet; O Romano; P Chavatte; M Chamaillard; P Desreumaux
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

4.  Site-specific modulation of white adipose tissue lipid metabolism by oleoyl-estrone and/or rosiglitazone in overweight rats.

Authors:  R Ferrer-Lorente; C Cabot; J A Fernández-López; M Alemany
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-02       Impact factor: 3.000

5.  Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model.

Authors:  T Ota; T Takamura; H Ando; E Nohara; H Yamashita; K Kobayashi
Journal:  Diabetologia       Date:  2003-05-27       Impact factor: 10.122

Review 6.  Metabolic and additional vascular effects of thiazolidinediones.

Authors:  Fabrice M A C Martens; Frank L J Visseren; Jacinthe Lemay; Eelco J P de Koning; Ton J Rabelink
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 7.  Effects of Grape Seed Proanthocyanidin Extract on Obesity.

Authors:  Miao Liu; Peng Yun; Ying Hu; Jiao Yang; Rim Bahadur Khadka; Xiaochun Peng
Journal:  Obes Facts       Date:  2020-02-28       Impact factor: 3.942

8.  cis9, trans11-Conjugated Linoleic Acid Differentiates Mouse 3T3-L1 Preadipocytes into Mature Small Adipocytes through Induction of Peroxisome Proliferator-activated Receptor γ.

Authors:  Satoru Sakuma; Yuki Nishioka; Ryohta Imanishi; Kenji Nishikawa; Hirotada Sakamoto; Junji Fujisawa; Koichiro Wada; Yoshinori Kamisaki; Yohko Fujimoto
Journal:  J Clin Biochem Nutr       Date:  2010-08-20       Impact factor: 3.114

9.  Expression of PPARγ and paraoxonase 2 correlated with Pseudomonas aeruginosa infection in cystic fibrosis.

Authors:  Phoebe E Griffin; Louise F Roddam; Yvonne C Belessis; Roxanne Strachan; Sean Beggs; Adam Jaffe; Margaret A Cooley
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

10.  Study of the effects of monacolin k and other constituents of red yeast rice on obesity, insulin-resistance, hyperlipidemia, and nonalcoholic steatohepatitis using a mouse model of metabolic syndrome.

Authors:  Makoto Fujimoto; Koichi Tsuneyama; Shao-Yuan Chen; Takeshi Nishida; Jiun-Liang Chen; Yen-Chen Chen; Takako Fujimoto; Johji Imura; Yutaka Shimada
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-20       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.